What is LOPJLB’s current signal on LEGN?

LOPJLB’s latest quantitative signal on Legend Biotech Corporation (LEGN) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is LEGN in?

Legend Biotech Corporation (LEGN) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does Legend Biotech Corporation (LEGN) do?

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of mu…

Where is Legend Biotech Corporation based / listed?

Legend Biotech Corporation is based in US, listed on NASDAQ.

Legend Biotech Corporation (LEGN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$18.71-2.14%Close

SELLRECOVERY · day 4

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $3.5B
Beta: 0.40
P/E (TTM): -37.44

Short % float: 8.21%
Days to cover: 7.1
SI change: -11.2%

1W: -3.16%
1M: -6.03%

vs SPY 1W: -4.71%
vs SPY 1M: -7.79%

Industry peers

FMP comparable companies · ranked by market cap

ALLOSELLAllogene Therapeutics, Inc.$504MCRISISQ -12$1.46-2.10%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news